首页 > 最新文献

Current Ophthalmology Reports最新文献

英文 中文
Changes in the oculas surface after hypotensive surgery 低血压手术后眼表的变化
IF 0.9 Q4 OPHTHALMOLOGY Pub Date : 2023-04-09 DOI: 10.17816/ov321181
Аnastasiia V. Аntonova, V. Nikolaenko, V. Brzheskiy, A. Vuks
BACKGROUND: Hundreds of studies are dedicated to the negative effects of glaucoma therapy on the ocular surface. At the same time, the state of the eye surface after successful hypotensive surgery, which resulted in the cessation or significant reduction of medical therapy, has not been studied. AIM: To identify ocular surface changes after glaucoma surgery. MATERIALS AND METHODS: The study group consisted of 475 consecutively enrolled patients who were operated during 20162020 in Saint Petersburg Multidisciplinary City Hospital No. 2 for primary open-angle unstable glaucoma, and then observed for 6 to 24 months. Trabeculectomy (TE) was used as the first hypotensive procedure (418 patients), as re-operation TE (25 patients) or Ahmed valve implantation (32 patients) were chosen. Using statistical methods, the dynamics of symptoms (OSDI) and signs [tear film break-up time (TBUT) and reflex tear production defined by Schirmer I test] depending on outcome (complete or partial success and total failure) were analyzed. RESULTS: The cessation of the pharmacological load due to the complete success of the surgery was accompanied by pronounced (two-fold) and long (for at least two years) decrease of OSDI scores. The obliged, even partial, return to instillations by patients, who were included into the subgroup of partial success, within six months, transformed the achieved differences into insignificant ones. TBUT at complete and partial success significantly increased at all end-points of the study, significantly differing from the similar indicator in the subgroup total failure. The results of the Schirmer I test against the background of complete success of the operation showed a statistically significant increase, compared to the baseline , delayed for six months, throughout the whole further follow-up period. Patients entering the partial success subgroup in 24 months after surgery, also showed a significant increase in tear secretion. The failure of glaucoma surgery was accompanied by a brief and insignificant improvement in all scores. CONCLUSIONS: The hypotensive surgery, which lead to complete success, was accompanied by a significant improvement of the ocular surface state. Restart of local therapy reduces achieved results. Failure of surgical treatment is associated with minimal fluctuations of the studied parameters.
背景:数以百计的研究致力于青光眼治疗对眼表的负面影响。同时,降压手术成功后导致药物治疗停止或显著减少的眼表状态尚未得到研究。目的:探讨青光眼术后眼表变化。材料与方法:研究组纳入2016 - 2020年期间在圣彼得堡第二多学科城市医院行原发性开角不稳定型青光眼手术的475例患者,随访6 - 24个月。首次降压手术采用小梁切除术(TE)(418例),再行TE手术(25例)或Ahmed瓣膜植入术(32例)。采用统计学方法,分析了症状(OSDI)和体征(泪膜破裂时间(TBUT)和Schirmer I试验定义的反射性泪液产生)取决于结果(完全或部分成功和完全失败)的动态。结果:由于手术的完全成功,药物负荷的停止伴随着OSDI评分的明显(两倍)和长期(至少两年)下降。那些被纳入部分成功亚组的病人,在六个月内被迫,甚至是部分地重新开始注射,把已经取得的差异变成了微不足道的差异。完全和部分成功的TBUT在研究的所有终点都显著增加,与完全失败亚组的类似指标明显不同。在手术完全成功的背景下,Schirmer I试验的结果显示,在整个后续随访期间,与基线相比,延迟了6个月,统计上显着增加。术后24个月进入部分成功亚组的患者泪液分泌也明显增加。青光眼手术失败后,所有评分均有短暂而不显著的改善。结论:降压手术完全成功,并伴有眼表状态的显著改善。重新开始局部治疗会降低已取得的效果。手术治疗的失败与所研究参数的最小波动有关。
{"title":"Changes in the oculas surface after hypotensive surgery","authors":"Аnastasiia V. Аntonova, V. Nikolaenko, V. Brzheskiy, A. Vuks","doi":"10.17816/ov321181","DOIUrl":"https://doi.org/10.17816/ov321181","url":null,"abstract":"BACKGROUND: Hundreds of studies are dedicated to the negative effects of glaucoma therapy on the ocular surface. At the same time, the state of the eye surface after successful hypotensive surgery, which resulted in the cessation or significant reduction of medical therapy, has not been studied. \u0000AIM: To identify ocular surface changes after glaucoma surgery. \u0000MATERIALS AND METHODS: The study group consisted of 475 consecutively enrolled patients who were operated during 20162020 in Saint Petersburg Multidisciplinary City Hospital No. 2 for primary open-angle unstable glaucoma, and then observed for 6 to 24 months. Trabeculectomy (TE) was used as the first hypotensive procedure (418 patients), as re-operation TE (25 patients) or Ahmed valve implantation (32 patients) were chosen. Using statistical methods, the dynamics of symptoms (OSDI) and signs [tear film break-up time (TBUT) and reflex tear production defined by Schirmer I test] depending on outcome (complete or partial success and total failure) were analyzed. \u0000RESULTS: The cessation of the pharmacological load due to the complete success of the surgery was accompanied by pronounced (two-fold) and long (for at least two years) decrease of OSDI scores. The obliged, even partial, return to instillations by patients, who were included into the subgroup of partial success, within six months, transformed the achieved differences into insignificant ones. TBUT at complete and partial success significantly increased at all end-points of the study, significantly differing from the similar indicator in the subgroup total failure. The results of the Schirmer I test against the background of complete success of the operation showed a statistically significant increase, compared to the baseline , delayed for six months, throughout the whole further follow-up period. Patients entering the partial success subgroup in 24 months after surgery, also showed a significant increase in tear secretion. The failure of glaucoma surgery was accompanied by a brief and insignificant improvement in all scores. \u0000CONCLUSIONS: The hypotensive surgery, which lead to complete success, was accompanied by a significant improvement of the ocular surface state. Restart of local therapy reduces achieved results. Failure of surgical treatment is associated with minimal fluctuations of the studied parameters.","PeriodicalId":10836,"journal":{"name":"Current Ophthalmology Reports","volume":"38 1","pages":""},"PeriodicalIF":0.9,"publicationDate":"2023-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87507642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical efficacy of early vitrectomy in patients with severe blunt ocular trauma 早期玻璃体切除术治疗严重钝性眼外伤的临床疗效
IF 0.9 Q4 OPHTHALMOLOGY Pub Date : 2023-04-09 DOI: 10.17816/ov116735
S. N. Subbotina, S. S. Shamkin, A. Stepanyants
BACKGROUND: Eye injury is an actual problem, occupying a leading position among the main causes of blindness and low vision, accounting for 22.8% in the structure of primary visual disability, of which 53% of cases are due to closed eye injury. Despite the development and widespread introduction into practice of methods of high-tech care for patients of this profile, there are a number of complications that poorly respond to treatment, ultimately leading to the loss of visual function of the injured eye. AIM: Evaluation of the effectiveness of early vitrectomy in patients with severe blunt ocular trauma, based on clinical results obtained during treatment and postoperative follow-up. MATERIALS AND METHODS: The study included 34 patients (34 eyes) with contusion-type eye injury. The mean age of patients was 39 years, among them 30 were men (88.24%) and 4 (11.76%) women. Patients were divided into 2 groups. Group 1 included 11 patients (10 men, 1 woman) with an open-type eye injury with a subconjunctival scleral rupture; upon admission, visual acuity varied from incorrect light projection to 0.01. In group 2, there were 23 patients (20 men, 3 women) with severe closed eye injury, upon admission to the hospital, visual acuity ranged from incorrect light projection to 0.06. In all cases, patients underwent subtotal three-port vitrectomy at an early date (up to 3 days) after injury. RESULTS: On the 1st day after surgery, there was an improvement in visual acuity in all patients. The follow-up period for patients was 6 months. All included patients had a stable anatomical result, no cases of subatrophy were noted, satisfactory functional results were achieved - visual acuity varied from 0.02 to 0.8. After 6 months, 32 out of 34 eyes (94.12%) showed no signs of proliferative vitreoretinopathy. In 2 patients (18.18%) from group 1, the development of proliferative vitreoretinopathy under silicone oil was revealed. Epiretinal membrane was diagnosed in 2 patients (8.7%) from group 2 and in 1 patient (9.09%) from group 1. CONCLUSIONS: Obtained clinical results of treatment of patients with severe blunt ocular trauma indicate the expediency of vitrectomy in early stages after injury, which is an effective treatment method. Long-term results demonstrate stable functional results for 6 months. Vitrectomy performed early after injury serves for prevention of proliferative vitreoretinopathy, but does not completely exclude its development. Performing surgery early after injury increases the prospects for preserving visual functions of the eye and is a positive prognostic factor.
背景:眼损伤是一个现实问题,在致盲和低视力的主要原因中占据主导地位,占原发性视力障碍结构的22.8%,其中53%的病例是由于闭眼损伤。尽管针对这类患者的高科技护理方法得到了发展和广泛应用,但仍有许多并发症对治疗反应不佳,最终导致受伤眼睛的视觉功能丧失。目的:根据治疗期间的临床结果及术后随访,评价早期玻璃体切除术治疗严重钝性眼外伤的疗效。材料与方法:本研究纳入挫伤型眼损伤患者34例(34只眼)。患者平均年龄39岁,其中男性30例(88.24%),女性4例(11.76%)。患者分为两组。1组11例(男10例,女1例)开放性眼损伤伴结膜下巩膜破裂;入院时,视力从不正确的光投射到0.01不等。2组患者23例(男20例,女3例),均为重度闭合性眼损伤,入院时视力从光投射不正确到0.06不等。在所有病例中,患者在受伤后早期(最多3天)接受了三孔玻璃体切除术。结果:术后第1天,所有患者的视力均有改善。患者随访6个月。所有患者解剖结果稳定,无亚萎缩病例,功能结果令人满意,视力从0.02到0.8不等。6个月后,34只眼中32只(94.12%)未见增殖性玻璃体视网膜病变迹象。1组2例(18.18%)患者在硅油作用下出现增生性玻璃体视网膜病变。2组2例(8.7%)诊断为视网膜外膜,1组1例(9.09%)。结论:已获得的治疗严重钝性眼外伤患者的临床结果表明,伤后早期行玻璃体切除术是一种有效的治疗方法。长期结果显示6个月的功能稳定。损伤后早期进行玻璃体切除术有助于预防增殖性玻璃体视网膜病变,但不能完全排除其发展。损伤后早期进行手术可以增加保留眼睛视觉功能的前景,是一个积极的预后因素。
{"title":"Clinical efficacy of early vitrectomy in patients with severe blunt ocular trauma","authors":"S. N. Subbotina, S. S. Shamkin, A. Stepanyants","doi":"10.17816/ov116735","DOIUrl":"https://doi.org/10.17816/ov116735","url":null,"abstract":"BACKGROUND: Eye injury is an actual problem, occupying a leading position among the main causes of blindness and low vision, accounting for 22.8% in the structure of primary visual disability, of which 53% of cases are due to closed eye injury. Despite the development and widespread introduction into practice of methods of high-tech care for patients of this profile, there are a number of complications that poorly respond to treatment, ultimately leading to the loss of visual function of the injured eye. \u0000AIM: Evaluation of the effectiveness of early vitrectomy in patients with severe blunt ocular trauma, based on clinical results obtained during treatment and postoperative follow-up. \u0000MATERIALS AND METHODS: The study included 34 patients (34 eyes) with contusion-type eye injury. The mean age of patients was 39 years, among them 30 were men (88.24%) and 4 (11.76%) women. Patients were divided into 2 groups. Group 1 included 11 patients (10 men, 1 woman) with an open-type eye injury with a subconjunctival scleral rupture; upon admission, visual acuity varied from incorrect light projection to 0.01. In group 2, there were 23 patients (20 men, 3 women) with severe closed eye injury, upon admission to the hospital, visual acuity ranged from incorrect light projection to 0.06. In all cases, patients underwent subtotal three-port vitrectomy at an early date (up to 3 days) after injury. \u0000RESULTS: On the 1st day after surgery, there was an improvement in visual acuity in all patients. The follow-up period for patients was 6 months. All included patients had a stable anatomical result, no cases of subatrophy were noted, satisfactory functional results were achieved - visual acuity varied from 0.02 to 0.8. After 6 months, 32 out of 34 eyes (94.12%) showed no signs of proliferative vitreoretinopathy. In 2 patients (18.18%) from group 1, the development of proliferative vitreoretinopathy under silicone oil was revealed. Epiretinal membrane was diagnosed in 2 patients (8.7%) from group 2 and in 1 patient (9.09%) from group 1. \u0000CONCLUSIONS: Obtained clinical results of treatment of patients with severe blunt ocular trauma indicate the expediency of vitrectomy in early stages after injury, which is an effective treatment method. Long-term results demonstrate stable functional results for 6 months. Vitrectomy performed early after injury serves for prevention of proliferative vitreoretinopathy, but does not completely exclude its development. Performing surgery early after injury increases the prospects for preserving visual functions of the eye and is a positive prognostic factor.","PeriodicalId":10836,"journal":{"name":"Current Ophthalmology Reports","volume":"7 1","pages":""},"PeriodicalIF":0.9,"publicationDate":"2023-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75165311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endophthalmitis risk factors associates with phacoemulsification (Literature review) 眼内炎与超声乳化术相关的危险因素(文献回顾)
IF 0.9 Q4 OPHTHALMOLOGY Pub Date : 2023-04-09 DOI: 10.17816/ov104740
Tatiana Yu. Bogdanova, A. Kulikov, E. V. Danilenko, Elena N. Kolosovskaya, L. Kraeva
The most frequent sources of microbial flora inside the eye are the ocular surface, foci of para-ocular infection of the patient. In vitreous samples from eyes with endophthalmitis microorganisms are revealed that are the saprophytic flora of the ocular surface. It is mainly represented by staphylococci, from which epidermal staphylococcus prevails quantitatively. Immunodeficiency states, diabetes mellitus, terminal liver and kidney diseases increase the risk of endophthalmitis development. Eradication of opportunistic pathogenic flora in the source loci, sanation of para-ocular infection, correction of somatic pathology by profile specialists is more relevant for endophthalmitis prevention. The problem of growing antibiotic resistance should also be considered. Thus, when selecting patients for surgery, one should be guided by the data on antibiotic resistance of the identified flora, pay attention to the presence of para-ocular infection and the systemic somatic status of the patient. This will provide a better vector for the development of recommendations for optimal prophylaxis.
眼内微生物菌群最常见的来源是患者的眼表、眼旁感染灶。在眼内炎的玻璃体样本中,发现了眼表面腐生菌群的微生物。主要以葡萄球菌为代表,其中表皮葡萄球菌在数量上占优势。免疫缺陷状态、糖尿病、晚期肝脏和肾脏疾病会增加眼内炎发展的风险。根除源位点的机会致病性菌群,眼旁感染的卫生,由侧写专家纠正躯体病理与预防眼内炎更相关。还应考虑到抗生素耐药性日益增长的问题。因此,在选择手术患者时,应以所鉴定菌群的抗生素耐药性数据为指导,注意是否存在眼旁感染和患者的全身躯体状态。这将为制定最佳预防建议提供更好的媒介。
{"title":"Endophthalmitis risk factors associates with phacoemulsification (Literature review)","authors":"Tatiana Yu. Bogdanova, A. Kulikov, E. V. Danilenko, Elena N. Kolosovskaya, L. Kraeva","doi":"10.17816/ov104740","DOIUrl":"https://doi.org/10.17816/ov104740","url":null,"abstract":"The most frequent sources of microbial flora inside the eye are the ocular surface, foci of para-ocular infection of the patient. In vitreous samples from eyes with endophthalmitis microorganisms are revealed that are the saprophytic flora of the ocular surface. It is mainly represented by staphylococci, from which epidermal staphylococcus prevails quantitatively. Immunodeficiency states, diabetes mellitus, terminal liver and kidney diseases increase the risk of endophthalmitis development. Eradication of opportunistic pathogenic flora in the source loci, sanation of para-ocular infection, correction of somatic pathology by profile specialists is more relevant for endophthalmitis prevention. The problem of growing antibiotic resistance should also be considered. Thus, when selecting patients for surgery, one should be guided by the data on antibiotic resistance of the identified flora, pay attention to the presence of para-ocular infection and the systemic somatic status of the patient. This will provide a better vector for the development of recommendations for optimal prophylaxis.","PeriodicalId":10836,"journal":{"name":"Current Ophthalmology Reports","volume":"27 1","pages":""},"PeriodicalIF":0.9,"publicationDate":"2023-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85080762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modern strategy and standards of treatment of lower eyelid skin malignant neoplasms 下眼睑皮肤恶性肿瘤的现代治疗策略与标准
IF 0.9 Q4 OPHTHALMOLOGY Pub Date : 2023-04-09 DOI: 10.17816/ov114946
A. Polyakov, Dmitry V. Davydov, I. Novikova, A. L. Sugaipov, O. Kuznetsova, Elena A. Naumova
Cases of surgical treatment of basal cell skin carcinoma of the lower eyelid are rarely described in the world literature. Perhaps this is due to the search for new non-surgical treatment methods or to the fact that this localization is poorly represented in the total incidence of basal cell skin cancer. However, the operative method, recommended as the main line of treatment by both domestic and foreign clinical recommendations, is still recognized as the most radical and aesthetically acceptable method of treatment. Non-radical treatment of the tumor leads, in turn, to relapses of the disease, to the emergence of systemic metastatic foci due to the lymphogenic and hematogenic spread of tumor cells. In the article we describe the experience of surgical treatment of patients suffering from basal cell skin carcinoma of the lower eyelid of varying degrees of extension.
手术治疗下眼睑基底细胞皮肤癌的病例在国际文献中很少有报道。这可能是由于寻找新的非手术治疗方法,或者是由于这种定位在基底细胞皮肤癌的总发病率中很少代表。然而,手术方法被国内外临床推荐为主要的治疗方法,仍然被认为是最彻底、最美观的治疗方法。肿瘤的非根治治疗反过来又导致疾病复发,由于肿瘤细胞的淋巴源性和血液源性扩散而出现全身转移灶。在本文中,我们描述了手术治疗的经验,患者的基底细胞皮肤癌的下眼睑不同程度的延伸。
{"title":"Modern strategy and standards of treatment of lower eyelid skin malignant neoplasms","authors":"A. Polyakov, Dmitry V. Davydov, I. Novikova, A. L. Sugaipov, O. Kuznetsova, Elena A. Naumova","doi":"10.17816/ov114946","DOIUrl":"https://doi.org/10.17816/ov114946","url":null,"abstract":"Cases of surgical treatment of basal cell skin carcinoma of the lower eyelid are rarely described in the world literature. Perhaps this is due to the search for new non-surgical treatment methods or to the fact that this localization is poorly represented in the total incidence of basal cell skin cancer. However, the operative method, recommended as the main line of treatment by both domestic and foreign clinical recommendations, is still recognized as the most radical and aesthetically acceptable method of treatment. Non-radical treatment of the tumor leads, in turn, to relapses of the disease, to the emergence of systemic metastatic foci due to the lymphogenic and hematogenic spread of tumor cells. In the article we describe the experience of surgical treatment of patients suffering from basal cell skin carcinoma of the lower eyelid of varying degrees of extension.","PeriodicalId":10836,"journal":{"name":"Current Ophthalmology Reports","volume":"26 1","pages":""},"PeriodicalIF":0.9,"publicationDate":"2023-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82522324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Review of Pharmacological Treatments for Presbyopia 老花眼的药物治疗综述
IF 0.9 Q4 OPHTHALMOLOGY Pub Date : 2023-01-21 DOI: 10.1007/s40135-023-00307-w
F. Vejarano, Jorge Alió, R. Iribarren
{"title":"Review of Pharmacological Treatments for Presbyopia","authors":"F. Vejarano, Jorge Alió, R. Iribarren","doi":"10.1007/s40135-023-00307-w","DOIUrl":"https://doi.org/10.1007/s40135-023-00307-w","url":null,"abstract":"","PeriodicalId":10836,"journal":{"name":"Current Ophthalmology Reports","volume":"11 1","pages":"13-19"},"PeriodicalIF":0.9,"publicationDate":"2023-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43983386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surfing the COVID-19 Tsunami with Teleophthalmology: the Advent of New Models of Eye Care. 用远距眼科技术应对COVID-19海啸:眼部护理新模式的出现。
IF 0.9 Q4 OPHTHALMOLOGY Pub Date : 2023-01-01 DOI: 10.1007/s40135-023-00308-9
Giselle Ricur, Joshua Reyes, Eduardo Alfonso, Raul Guillermo Marino

Purpose of review: In this article, we reviewed the impact resulting from the COVID-19 pandemic on the traditional model of care in ophthalmology.

Recent findings: Though virtual eye care has been present for more than 20 years, the COVID-19 pandemic has established a precedent to seriously consider its role in the evolving paradigm of vision and eye care. New hybrid models of care have enhanced or replaced traditional synchronous and asynchronous visits. The increased use of smart phoneography and mobile applications enhanced the remote examination of patients. Use of e-learning became a mainstream tool to continue accessing education and training.

Summary: Teleophthalmology has demonstrated its value for screening, examining, diagnosing, monitoring treatment, and increasing access to education. However, much of the progress made following the COVID-19 pandemic is at risk of being lost as society pushes to reestablish normalcy. Further studies during the new norm are required to prove a more permanent role for virtual eye care.

综述目的:本文综述了2019冠状病毒病大流行对眼科传统护理模式的影响。最近的发现:尽管虚拟眼保健已经存在了20多年,但COVID-19大流行已经树立了一个先例,让人们认真考虑其在不断发展的视力和眼保健范例中的作用。新的混合护理模式加强或取代了传统的同步和非同步就诊。智能语音和移动应用程序的使用增加了对患者的远程检查。使用电子学习已成为继续接受教育和培训的主流工具。摘要:远视医学在筛查、检查、诊断、监测治疗和增加教育机会方面已经证明了它的价值。然而,随着社会努力恢复正常,2019冠状病毒病大流行后取得的大部分进展面临丧失的风险。在新规范期间,需要进一步的研究来证明虚拟眼科护理的更持久的作用。
{"title":"Surfing the COVID-19 Tsunami with Teleophthalmology: the Advent of New Models of Eye Care.","authors":"Giselle Ricur,&nbsp;Joshua Reyes,&nbsp;Eduardo Alfonso,&nbsp;Raul Guillermo Marino","doi":"10.1007/s40135-023-00308-9","DOIUrl":"https://doi.org/10.1007/s40135-023-00308-9","url":null,"abstract":"<p><strong>Purpose of review: </strong>In this article, we reviewed the impact resulting from the COVID-19 pandemic on the traditional model of care in ophthalmology.</p><p><strong>Recent findings: </strong>Though virtual eye care has been present for more than 20 years, the COVID-19 pandemic has established a precedent to seriously consider its role in the evolving paradigm of vision and eye care. New hybrid models of care have enhanced or replaced traditional synchronous and asynchronous visits. The increased use of smart phoneography and mobile applications enhanced the remote examination of patients. Use of e-learning became a mainstream tool to continue accessing education and training.</p><p><strong>Summary: </strong>Teleophthalmology has demonstrated its value for screening, examining, diagnosing, monitoring treatment, and increasing access to education. However, much of the progress made following the COVID-19 pandemic is at risk of being lost as society pushes to reestablish normalcy. Further studies during the new norm are required to prove a more permanent role for virtual eye care.</p>","PeriodicalId":10836,"journal":{"name":"Current Ophthalmology Reports","volume":"11 1","pages":"1-12"},"PeriodicalIF":0.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883823/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10717730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
A systematic review of acute zonal occult outer retinopathy with a focus on attempted treatment modalities. 对急性区域性隐匿性外视网膜病变的系统回顾,重点是尝试治疗方式。
IF 0.9 Q4 OPHTHALMOLOGY Pub Date : 2022-12-01 DOI: 10.1007/s40135-022-00305-4
Benjamin R Lin, Jonathan F Russell, Hasenin Al-Khersan, Raquel Goldhardt
{"title":"A systematic review of acute zonal occult outer retinopathy with a focus on attempted treatment modalities.","authors":"Benjamin R Lin, Jonathan F Russell, Hasenin Al-Khersan, Raquel Goldhardt","doi":"10.1007/s40135-022-00305-4","DOIUrl":"10.1007/s40135-022-00305-4","url":null,"abstract":"","PeriodicalId":10836,"journal":{"name":"Current Ophthalmology Reports","volume":"10 4","pages":"168-178"},"PeriodicalIF":0.9,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894323/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9236774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Outcomes of Pythium keratitis: a meta-analysis of individual patient data. 角膜炎的预后:个体患者数据的荟萃分析。
IF 0.9 Q4 OPHTHALMOLOGY Pub Date : 2022-12-01 Epub Date: 2022-11-10 DOI: 10.1007/s40135-022-00302-7
Binh Cao, Vishnu Teja Gonugunta, Naveen Radhakrishnan, Prajna Lalitha, Bharat Gurnani, Kirandeep Kaur, Geetha Iyer, Shweta Agarwal, Bhaskar Srinivasan, Jeremy D Keenan, N Venkatesh Prajna

Background: Pythium keratitis is a difficult-to-treat corneal infection.

Methods: A meta-analysis of individual patient data from observational studies of Pythium keratitis was performed. The outcomes of interest were therapeutic penetrating keratoplasty (TPK) and globe removal (evisceration, enucleation, or exenteration); the main exposures were linezolid and azithromycin use.

Findings: Of 46 eligible articles, individual patient data were available for 306 eyes (34 studies). Pythium keratitis was associated with high rates of TPK (80%, 95%CI 70-87%) and globe removal (25%, 95%CI 13-43). In multivariable models adjusting for age and country, fewer TPKs were performed in patients treated with azithromycin (RR=0.80, 95%CI 0.67-0.96; P=0.04) and linezolid (RR=0.82, 95%CI 0.67-0.99; P=0.02).

Conclusions: Studies of Pythium keratitis reported high rates of TPK and globe removal. Use of azithromycin and linezolid was associated with a lower rate of TPK. While promising, these results should be interpreted with caution given the biases inherent to observational studies.

背景:角膜炎是一种难治性角膜感染。方法:对来自角膜炎观察性研究的个体患者数据进行荟萃分析。关注的结果是治疗性穿透性角膜移植术(TPK)和眼球摘除(剜出、去核或剜出);主要暴露是利奈唑胺和阿奇霉素的使用。结果:在46篇符合条件的文章中,可获得306只眼睛(34项研究)的个体患者数据。角膜炎与高TPK率(80%,95%CI 70-87%)和球清除率(25%,95%CI 13-43)相关。在调整年龄和国家的多变量模型中,接受阿奇霉素治疗的患者较少进行TPKs (RR=0.80, 95%CI 0.67-0.96;P=0.04)和利奈唑胺(RR=0.82, 95%CI 0.67-0.99;P = 0.02)。结论:对角膜炎的研究报告了较高的TPK和球体去除率。使用阿奇霉素和利奈唑胺与较低的TPK率相关。虽然有希望,但考虑到观察性研究固有的偏差,这些结果应该谨慎解释。
{"title":"Outcomes of Pythium keratitis: a meta-analysis of individual patient data.","authors":"Binh Cao, Vishnu Teja Gonugunta, Naveen Radhakrishnan, Prajna Lalitha, Bharat Gurnani, Kirandeep Kaur, Geetha Iyer, Shweta Agarwal, Bhaskar Srinivasan, Jeremy D Keenan, N Venkatesh Prajna","doi":"10.1007/s40135-022-00302-7","DOIUrl":"10.1007/s40135-022-00302-7","url":null,"abstract":"<p><strong>Background: </strong>Pythium keratitis is a difficult-to-treat corneal infection.</p><p><strong>Methods: </strong>A meta-analysis of individual patient data from observational studies of Pythium keratitis was performed. The outcomes of interest were therapeutic penetrating keratoplasty (TPK) and globe removal (evisceration, enucleation, or exenteration); the main exposures were linezolid and azithromycin use.</p><p><strong>Findings: </strong>Of 46 eligible articles, individual patient data were available for 306 eyes (34 studies). Pythium keratitis was associated with high rates of TPK (80%, 95%CI 70-87%) and globe removal (25%, 95%CI 13-43). In multivariable models adjusting for age and country, fewer TPKs were performed in patients treated with azithromycin (RR=0.80, 95%CI 0.67-0.96; <i>P</i>=0.04) and linezolid (RR=0.82, 95%CI 0.67-0.99; <i>P</i>=0.02).</p><p><strong>Conclusions: </strong>Studies of Pythium keratitis reported high rates of TPK and globe removal. Use of azithromycin and linezolid was associated with a lower rate of TPK. While promising, these results should be interpreted with caution given the biases inherent to observational studies.</p>","PeriodicalId":10836,"journal":{"name":"Current Ophthalmology Reports","volume":"10 4","pages":"198-208"},"PeriodicalIF":0.9,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10211475/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9553049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Ocular Surface Ion Transport and Dry Eye Disease. 眼表面离子迁移与干眼症
IF 0.9 Q4 OPHTHALMOLOGY Pub Date : 2022-12-01 Epub Date: 2022-10-20 DOI: 10.1007/s40135-022-00295-3
Ethan S Lindgren, Onur Cil, Alan S Verkman, Neel D Pasricha

Purpose of review: To review the role of ocular surface epithelial (corneal and conjunctival) ion transporters in the pathogenesis and treatment of dry eye disease (DED).

Recent findings: Currently, anti-inflammatory agents are the mainstay of DED treatment, though there are several agents in development that target ion transport proteins on the ocular surface, acting by pro-secretory or anti-absorptive mechanisms to increase the tear fluid Film volume. Activation or inhibition of selected ion transporters can alter tear fluid osmolality, driving water transport onto the ocular surface via osmosis. Several ion transporters have been proposed as potential therapeutic targets for DED, including the cystic fibrosis transmembrane conductance regulator (CFTR), calcium-activated chloride channels (CaCCs), and the epithelial sodium channel (ENaC).

Summary: Ocular surface epithelial cell ion transporters are promising targets for pro-secretory and anti-absorptive therapies of DED.

综述目的:回顾眼表上皮(角膜和结膜)离子转运体在干眼症(DED)发病机制和治疗中的作用:目前,抗炎药物是治疗干眼症的主要药物,但也有几种药物正在研发中,这些药物以眼表面的离子转运蛋白为靶点,通过促进分泌或抗吸收机制增加泪液膜容量。激活或抑制特定的离子转运体可改变泪液渗透压,通过渗透作用将水分转运到眼表。摘要:眼表上皮细胞离子转运体是促进分泌和抗吸收治疗 DED 的潜在靶点。
{"title":"Ocular Surface Ion Transport and Dry Eye Disease.","authors":"Ethan S Lindgren, Onur Cil, Alan S Verkman, Neel D Pasricha","doi":"10.1007/s40135-022-00295-3","DOIUrl":"10.1007/s40135-022-00295-3","url":null,"abstract":"<p><strong>Purpose of review: </strong>To review the role of ocular surface epithelial (corneal and conjunctival) ion transporters in the pathogenesis and treatment of dry eye disease (DED).</p><p><strong>Recent findings: </strong>Currently, anti-inflammatory agents are the mainstay of DED treatment, though there are several agents in development that target ion transport proteins on the ocular surface, acting by pro-secretory or anti-absorptive mechanisms to increase the tear fluid Film volume. Activation or inhibition of selected ion transporters can alter tear fluid osmolality, driving water transport onto the ocular surface via osmosis. Several ion transporters have been proposed as potential therapeutic targets for DED, including the cystic fibrosis transmembrane conductance regulator (CFTR), calcium-activated chloride channels (CaCCs), and the epithelial sodium channel (ENaC).</p><p><strong>Summary: </strong>Ocular surface epithelial cell ion transporters are promising targets for pro-secretory and anti-absorptive therapies of DED.</p>","PeriodicalId":10836,"journal":{"name":"Current Ophthalmology Reports","volume":"10 1","pages":"188-197"},"PeriodicalIF":0.9,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10783585/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49646151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Update on the Light-Adjustable Lens (LAL) 可调光镜头(LAL)的最新进展
IF 0.9 Q4 OPHTHALMOLOGY Pub Date : 2022-11-28 DOI: 10.1007/s40135-022-00306-3
Gabriel A Quesada, K. Waltz, Rodrigo A Quesada, León Colindres, Eduardo Alas, Amarilis Portillo, Rafael Perez-Varela, Pablo Ortiz
{"title":"Update on the Light-Adjustable Lens (LAL)","authors":"Gabriel A Quesada, K. Waltz, Rodrigo A Quesada, León Colindres, Eduardo Alas, Amarilis Portillo, Rafael Perez-Varela, Pablo Ortiz","doi":"10.1007/s40135-022-00306-3","DOIUrl":"https://doi.org/10.1007/s40135-022-00306-3","url":null,"abstract":"","PeriodicalId":10836,"journal":{"name":"Current Ophthalmology Reports","volume":"10 1","pages":"228 - 232"},"PeriodicalIF":0.9,"publicationDate":"2022-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47476708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Ophthalmology Reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1